NO971238L - Fluoralkyl- og fluoralkoksy-substituerte heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav - Google Patents
Fluoralkyl- og fluoralkoksy-substituerte heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse deravInfo
- Publication number
- NO971238L NO971238L NO971238A NO971238A NO971238L NO 971238 L NO971238 L NO 971238L NO 971238 A NO971238 A NO 971238A NO 971238 A NO971238 A NO 971238A NO 971238 L NO971238 L NO 971238L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- preparation
- fluoroalkoxy
- fluoroalkyl
- substituted
- Prior art date
Links
- 125000003709 fluoroalkyl group Chemical group 0.000 title abstract 2
- 239000003152 bradykinin antagonist Substances 0.000 title 1
- 125000000623 heterocyclic group Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- -1 r3 and r4 mean H Chemical class 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 101800004538 Bradykinin Proteins 0.000 abstract 1
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 abstract 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 abstract 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102100035792 Kininogen-1 Human genes 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 abstract 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D257/12—Six-membered rings having four nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19610784A DE19610784A1 (de) | 1996-03-19 | 1996-03-19 | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971238D0 NO971238D0 (no) | 1997-03-18 |
| NO971238L true NO971238L (no) | 1997-09-22 |
Family
ID=7788755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971238A NO971238L (no) | 1996-03-19 | 1997-03-18 | Fluoralkyl- og fluoralkoksy-substituerte heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5859025A (cs) |
| EP (1) | EP0796848B1 (cs) |
| JP (1) | JP4199315B2 (cs) |
| KR (1) | KR970065522A (cs) |
| AR (1) | AR006261A1 (cs) |
| AT (1) | ATE242215T1 (cs) |
| AU (1) | AU1628397A (cs) |
| BR (1) | BR9701332A (cs) |
| CA (1) | CA2199925A1 (cs) |
| CZ (1) | CZ81097A3 (cs) |
| DE (2) | DE19610784A1 (cs) |
| DK (1) | DK0796848T3 (cs) |
| ES (1) | ES2196207T3 (cs) |
| HR (1) | HRP970155A2 (cs) |
| HU (1) | HUP9700595A1 (cs) |
| ID (1) | ID16274A (cs) |
| IL (1) | IL120477A0 (cs) |
| NO (1) | NO971238L (cs) |
| PL (1) | PL318924A1 (cs) |
| PT (1) | PT796848E (cs) |
| SI (1) | SI0796848T1 (cs) |
| SK (1) | SK34897A3 (cs) |
| TR (1) | TR199700206A2 (cs) |
| ZA (1) | ZA972328B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19712960A1 (de) * | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| ATE257479T1 (de) * | 1999-12-10 | 2004-01-15 | Pfizer | 5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten |
| EP1495017A2 (en) * | 2002-04-10 | 2005-01-12 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| EP1914236A1 (en) | 2002-04-10 | 2008-04-23 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| US7256207B2 (en) * | 2003-08-20 | 2007-08-14 | Irm Llc | Inhibitors of cathepsin S |
| KR20070116060A (ko) | 2005-03-01 | 2007-12-06 | 와이어쓰 | 신놀린 화합물 및 간 ｘ 수용체 조절제로서의 이의 용도 |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR085073A1 (es) * | 2012-01-11 | 2013-09-11 | Richmond Sa Com Ind Y Financiera Lab | Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden |
| IL274883B2 (en) | 2017-11-24 | 2023-11-01 | Pharvaris Netherlands B V | BRADYKININ B2 receptor antagonists |
| AR118982A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| UY38707A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Nuevos antagonistas cíclicos del receptor b2 de bradiquinina |
| BR112024002215A2 (pt) | 2021-08-05 | 2024-04-30 | Pharvaris Gmbh | Composição à base de lipídios para administração oral de antagonistas do receptor b2 da bradicinina |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| HRP20260166T1 (hr) | 2022-03-25 | 2026-03-27 | Pharvaris Gmbh | Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora |
| EP4499100A1 (en) | 2022-03-25 | 2025-02-05 | Pharvaris GmbH | Therapeutic uses of bradykinin b2-receptor antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5216165A (en) * | 1990-10-03 | 1993-06-01 | American Home Products Corporation | N-substituted aminoquinolines as analgesic agents |
| US5212182A (en) * | 1990-10-03 | 1993-05-18 | American Home Products Corpooration | Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics |
| US5438064A (en) * | 1991-12-23 | 1995-08-01 | American Home Products Corporation | Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| WO1996005202A1 (en) * | 1994-08-17 | 1996-02-22 | Nippon Hypox Laboratories Inc. | Imidazoquinoline derivative |
| WO1996013485A1 (en) * | 1994-10-27 | 1996-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
-
1996
- 1996-03-19 DE DE19610784A patent/DE19610784A1/de not_active Withdrawn
-
1997
- 1997-03-05 ES ES97103611T patent/ES2196207T3/es not_active Expired - Lifetime
- 1997-03-05 AT AT97103611T patent/ATE242215T1/de not_active IP Right Cessation
- 1997-03-05 DK DK97103611T patent/DK0796848T3/da active
- 1997-03-05 PT PT97103611T patent/PT796848E/pt unknown
- 1997-03-05 EP EP97103611A patent/EP0796848B1/de not_active Expired - Lifetime
- 1997-03-05 SI SI9730572T patent/SI0796848T1/xx unknown
- 1997-03-05 DE DE59710191T patent/DE59710191D1/de not_active Expired - Lifetime
- 1997-03-12 PL PL97318924A patent/PL318924A1/xx unknown
- 1997-03-13 CA CA002199925A patent/CA2199925A1/en not_active Abandoned
- 1997-03-17 TR TR97/00206A patent/TR199700206A2/xx unknown
- 1997-03-17 CZ CZ97810A patent/CZ81097A3/cs unknown
- 1997-03-17 KR KR1019970008899A patent/KR970065522A/ko not_active Withdrawn
- 1997-03-17 ID IDP970863A patent/ID16274A/id unknown
- 1997-03-17 AU AU16283/97A patent/AU1628397A/en not_active Abandoned
- 1997-03-17 HU HU9700595A patent/HUP9700595A1/hu unknown
- 1997-03-17 SK SK348-97A patent/SK34897A3/sk unknown
- 1997-03-17 AR ARP970101058A patent/AR006261A1/es unknown
- 1997-03-18 HR HR19610784.9A patent/HRP970155A2/xx not_active Application Discontinuation
- 1997-03-18 JP JP06474897A patent/JP4199315B2/ja not_active Expired - Lifetime
- 1997-03-18 ZA ZA9702328A patent/ZA972328B/xx unknown
- 1997-03-18 IL IL12047797A patent/IL120477A0/xx unknown
- 1997-03-18 BR BR9701332A patent/BR9701332A/pt not_active Application Discontinuation
- 1997-03-18 US US08/819,351 patent/US5859025A/en not_active Expired - Lifetime
- 1997-03-18 NO NO971238A patent/NO971238L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL318924A1 (en) | 1997-09-29 |
| BR9701332A (pt) | 1998-08-18 |
| PT796848E (pt) | 2003-08-29 |
| DK0796848T3 (da) | 2003-09-22 |
| EP0796848B1 (de) | 2003-06-04 |
| AR006261A1 (es) | 1999-08-11 |
| JPH107656A (ja) | 1998-01-13 |
| HU9700595D0 (en) | 1997-05-28 |
| TR199700206A2 (xx) | 1997-10-21 |
| HRP970155A2 (en) | 1998-04-30 |
| AU1628397A (en) | 1997-09-25 |
| NO971238D0 (no) | 1997-03-18 |
| SK34897A3 (en) | 1998-01-14 |
| DE19610784A1 (de) | 1997-09-25 |
| CA2199925A1 (en) | 1997-09-19 |
| ATE242215T1 (de) | 2003-06-15 |
| ES2196207T3 (es) | 2003-12-16 |
| HUP9700595A1 (hu) | 2000-08-28 |
| ID16274A (id) | 1997-09-18 |
| IL120477A0 (en) | 1997-07-13 |
| SI0796848T1 (en) | 2003-12-31 |
| EP0796848A1 (de) | 1997-09-24 |
| JP4199315B2 (ja) | 2008-12-17 |
| CZ81097A3 (en) | 1997-10-15 |
| MX9702028A (es) | 1997-09-30 |
| KR970065522A (ko) | 1997-10-13 |
| US5859025A (en) | 1999-01-12 |
| DE59710191D1 (de) | 2003-07-10 |
| ZA972328B (en) | 1997-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9804105A (es) | Antagonistas de taquicininas a base de piperidonas. | |
| ES8400390A1 (es) | Un procedimiento para la preparacion de derivados de 2-fenileta-nolamina. | |
| AU555323B2 (en) | Esters of phosphinyl alkanoyl substituted prolines | |
| ES8407029A1 (es) | Procedimiento para la produccion de n-aril-sulfonil-n'-pirimidil-ureas. | |
| MX9709951A (es) | Derivados de benzamida y su uso como antagonistas de vasopresina. | |
| ZA92969B (en) | 5-heteroyl indole derivatives. | |
| ES8203364A1 (es) | Un procedimiento para la preparacion de un derivado de ani- lina. | |
| ZA976654B (en) | Chroman derivatives. | |
| HUP9700595A1 (hu) | Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása | |
| JPS5359675A (en) | Aminoalcohol derivatives | |
| EP0375223A3 (en) | Novel compounds | |
| ES8506647A1 (es) | Procedimiento para la obtencion de derivados de fenilsulfonilguanidina sustituidos de efecto herbicida | |
| DK169989A (da) | Heterocyclisk substituerede alkyl- og alkenylsulfonylurinstoffer, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider og plantevaekstregulerende midler | |
| HUT66734A (en) | Herbicidal sulphonyl ureas, process and intermediates for production the same | |
| ZA953726B (en) | Cyclohexane derivatives process for their preparation and the use of the compounds for the treatment of diseases | |
| TW334428B (en) | Novel benzodiazepine derivatives | |
| EP0158956A3 (en) | 4-(nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds | |
| EP0239064A3 (en) | Herbicidal compounds, their production and use | |
| ES8402589A1 (es) | Nuevo procedimiento para la fabricacion de derivados de la 5,6,7,8-tetrahidro-1,6-naftridina. | |
| NZ304988A (en) | 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives and their use | |
| DE69525145D1 (en) | Carbamoylmethylharnstoffderivate | |
| ES8801271A1 (es) | Procedimiento para preparar compuestos tetraoxo | |
| DE59409756D1 (de) | 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als herzfrequenzsenkendes Mittel | |
| ZA869376B (en) | New fluorine-containing 1,4-dihydropyridines,process for their preparation and their use as medicaments | |
| HUT38307A (en) | Process for preparing new 9-halogenated prostaglandins |